SCHEMBL1526048

SCHEMBL1526048

CC(=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1N

nearest known ligand 0.51

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PYGB P11216 7/20 0.51
GAA P10253 1/20 0.51
CA2 P00918 5/20 0.49
CA9 Q16790 5/20 0.49
CA1 P00915 4/20 0.49
CA12 O43570 3/20 0.45
ALDH1A1 P00352 1/20 0.45
THRB P10828 1/20 0.45
MAPK1 P28482 2/20 0.44
TSHR P16473 1/20 0.43
OGA O60502 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1534335 1.00 PYGB (0.51) PYGBGAACA2CA9CA1
Phosphoric Acid SCHEMBL30415140 0.94 CA2 (0.48) PYGBGAACA2CA9CA1
SCHEMBL7149670 0.86 PYGB (0.67) PYGBGAACA2CA9CA1
SCHEMBL468706 0.86 PYGB (0.67) PYGBGAACA2CA9CA1
SCHEMBL7150986 0.84 PYGB (0.70) PYGBGAACA2CA9CA1
SCHEMBL7150977 0.84 PYGB (0.70) PYGBGAACA2CA9CA1
SCHEMBL488948 0.84 PYGB (0.70) PYGBGAACA2CA9CA1
SCHEMBL12510566 0.84 PYGB (0.70) PYGBGAACA2CA9CA1
SCHEMBL4388634 0.84 PYGB (0.70) PYGBGAACA2CA9CA1
SCHEMBL1582415 0.84 PYGB (0.70) PYGBGAACA2CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313905-A1 METHODS AND COMPOSITIONS FOR IMPROVED PSYCHOLOGICAL AND RESILIENCE MEASURES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2025-10-09 US disclosed
US-11001824-B1 Carbohydrate-binding protein UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2021-05-11 US disclosed
US-20210017402-A1 ANTI-FOULING PAINTS AND COATINGS REACTIVE SURFACES, LTD., LLP (US) 2021-01-21 US disclosed
US-20200354588-A1 ANTI-FOULING PAINTS AND COATINGS REACTIVE SURFACES, LTD., LLP (US) 2020-11-12 US disclosed
EP-3132031-B1 CARBOHYDRATE-BINDING PROTEIN UNIV GEORGIA (US) 2020-10-21 EP disclosed
US-20200109297-A1 ENZYMATIC ANTIMICROBIAL AND ANTIFOULING COATINGS AND POLYMERIC MATERIALS REACTIVE SURFACES, LTD., LLP (US) 2020-04-09 US disclosed
US-20170191049-A1 CARBOHYDRATE-BINDING PROTEIN UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2017-07-06 US disclosed
US-20150191607-A1 Anti-fouling Paints and Coatings REACTIVE SURFACES, LTD (US) 2015-07-09 US disclosed
US-20140196631-A1 VISUAL ASSAYS FOR COATINGS INCORPORATING BIOACTIVE ENZYMES FOR CATALYTIC FUNCTIONS REACTIVE SURFACE, LTD. (US) 2014-07-17 US disclosed
US-20140193889-A1 ENZYMATIC ANTIMICROBIAL AND ANTIFOULING COATINGS AND POLYMERIC MATERIALS REACTIVE SURFACES, LTD. (US) 2014-07-10 US disclosed
US-20120097194-A1 Polymeric Coatings Incorporating Bioactive Enzymes for Catalytic Function REACTIVE SURFACES, LTD. (US) 2012-04-26 US disclosed
US-20110250626-A1 Visual Assays for Coatings Incorporating Bioactive Enzymes for Catalytic Functions REACTIVE SURFACES, LTD. (US) 2011-10-13 US disclosed
US-20110240064-A1 Polymeric Coatings Incorporating Bioactive Enzymes for Cleaning a Surface REACTIVE SURFACES, LTD. (US) 2011-10-06 US disclosed
US-20110070376-A1 Anti-fouling Paints & Coatings REACTIVE SURFACES, LTD. (US) 2011-03-24 US disclosed
US-20100233146-A1 Coatings and Surface Treatments Having Active Enzymes and Peptides REACTIVE SURFACES, LTD. (US) 2010-09-16 US disclosed
US-20100210745-A1 Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes REACTIVE SURFACES, LTD. (US) 2010-08-19 US disclosed
US-20090238811-A1 Enzymatic Antimicrobial and Antifouling Coatings and Polymeric Materials REACTIVE SURFACES LTD. 2009-09-24 US disclosed
EP-1440165-A4 METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF CELLULAR PROLIFERATION DISORDERS USING 25943 MILLENNIUM PHARM INC (US) 2005-03-30 EP disclosed
EP-1440165-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF CELLULAR PROLIFERATION DISORDERS USING 25943 Millennium Pharmaceuticals, Inc. (US) 2004-07-28 EP disclosed
WO-2003038113-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF CELLULAR PROLIFERATION DISORDERS USING 25943 MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-05-08 WO disclosed